Thomas Schaeffer

1.3k total citations
26 papers, 854 citations indexed

About

Thomas Schaeffer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Thomas Schaeffer has authored 26 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Thomas Schaeffer's work include Peptidase Inhibition and Analysis (5 papers), Chemical Synthesis and Analysis (4 papers) and Hormonal Regulation and Hypertension (4 papers). Thomas Schaeffer is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Chemical Synthesis and Analysis (4 papers) and Hormonal Regulation and Hypertension (4 papers). Thomas Schaeffer collaborates with scholars based in United States, Germany and United Kingdom. Thomas Schaeffer's co-authors include Bernard Rubin, Robert J. Laffan, Barry Gold, John P. High, M.E. Goldberg, J. Eileen Bird, Magdi M. Asaad, N. C. Trippodo, Jeffrey A. Robl and Stephen C. Lenhard and has published in prestigious journals such as Diabetes, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas Schaeffer

24 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Schaeffer United States 16 375 303 121 104 99 26 854
Takeshi Tani Japan 15 195 0.5× 229 0.8× 63 0.5× 31 0.3× 78 0.8× 46 764
Carol A. Sargent United States 18 429 1.1× 201 0.7× 97 0.8× 35 0.3× 248 2.5× 36 932
Serge Simonet France 17 237 0.6× 236 0.8× 86 0.7× 50 0.5× 342 3.5× 39 842
Maria Rosaria Rusciano Italy 17 334 0.9× 166 0.5× 102 0.8× 87 0.8× 82 0.8× 37 839
Tetsuhiro Kubota Japan 12 198 0.5× 99 0.3× 135 1.1× 46 0.4× 79 0.8× 37 572
Seiji Umemoto Japan 19 367 1.0× 654 2.2× 24 0.2× 51 0.5× 198 2.0× 61 1.2k
Jan‐Arne Björkman Sweden 16 240 0.6× 522 1.7× 50 0.4× 35 0.3× 45 0.5× 38 919
Fushun Yu Taiwan 15 418 1.1× 573 1.9× 17 0.1× 68 0.7× 126 1.3× 18 1.1k
Benjamin Lauzier France 19 343 0.9× 237 0.8× 47 0.4× 30 0.3× 147 1.5× 64 949
Emilie Dubois‐Deruy France 14 410 1.1× 245 0.8× 58 0.5× 44 0.4× 129 1.3× 25 922

Countries citing papers authored by Thomas Schaeffer

Since Specialization
Citations

This map shows the geographic impact of Thomas Schaeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schaeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schaeffer more than expected).

Fields of papers citing papers by Thomas Schaeffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schaeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schaeffer. The network helps show where Thomas Schaeffer may publish in the future.

Co-authorship network of co-authors of Thomas Schaeffer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schaeffer. A scholar is included among the top collaborators of Thomas Schaeffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schaeffer. Thomas Schaeffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rill, Georg, et al.. (2024). Friction modeling from a practical point of view. Multibody System Dynamics. 63(1-2). 141–158. 5 indexed citations
2.
Schaeffer, Thomas, et al.. (2024). Vor- und Nachteile einer Lumped-Mass-Modellierung von Förderbändern am Beispiel eines Zwei-Walzensystems. Forschung im Ingenieurwesen. 88(1).
3.
Rill, Georg, et al.. (2023). LuGre or not LuGre. Multibody System Dynamics. 60(2). 191–218. 13 indexed citations
4.
Schaeffer, Thomas, et al.. (2020). Arrhythmogenic Antitussive: A Case of Pediatric Benzonatate Overdose With Torsades de Pointes, Cardiac Arrest, and Complete Recovery Without Neurologic Deficits. The Journal of Pediatric Pharmacology and Therapeutics. 25(7). 642–646. 4 indexed citations
5.
Rill, Georg & Thomas Schaeffer. (2014). Grundlagen und Methodik der Mehrkörpersimulation. DIAL (Catholic University of Leuven). 3 indexed citations
6.
Legos, Jeffrey J., Stephen C. Lenhard, Thomas Schaeffer, et al.. (2008). SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Experimental Neurology. 212(1). 53–62. 35 indexed citations
7.
Wedding, Ulrich, Bernd Roehrig, Almuth Klippstein, et al.. (2007). Comorbidity in patients with cancer: Prevalence and severity measured by cumulative illness rating scale. Critical Reviews in Oncology/Hematology. 61(3). 269–276. 68 indexed citations
8.
9.
10.
Purcell, Jeanette E., Stephen C. Lenhard, Ray F. White, et al.. (2003). Strain-dependent response to cerebral ischemic preconditioning: differences between spontaneously hypertensive and stroke prone spontaneously hypertensive rats. Neuroscience Letters. 339(2). 151–155. 20 indexed citations
11.
Lenhard, Stephen C., Sandhya S. Nerurkar, Thomas Schaeffer, et al.. (2003). p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 2. Improved Renal Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Journal of Pharmacology and Experimental Therapeutics. 307(3). 939–946. 14 indexed citations
12.
Jucker, Beat M., Thomas Schaeffer, Thomas McIntosh, et al.. (2002). Normalization of Skeletal Muscle Glycogen Synthesis and Glycolysis in Rosiglitazone-Treated Zucker Fatty Rats. Diabetes. 51(7). 2066–2073. 23 indexed citations
13.
Schaeffer, Thomas, et al.. (2000). Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality.. PubMed. 1(4). 452–63. 12 indexed citations
14.
Trippodo, N. C., Jeffrey A. Robl, Magdi M. Asaad, et al.. (1995). Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 745–752. 74 indexed citations
15.
Robl, Jeffrey A., Ligaya M. Simpkins, Denis E. Ryono, et al.. (1995). ChemInform Abstract: Dual Metalloprotease Inhibitors. Part 3. Utilization of Bicyclic and Monocyclic Diazepinone Based Mercaptoacetyls.. ChemInform. 26(9). 1 indexed citations
16.
Robl, Jeffrey A., Chong‐Qing Sun, Ligaya M. Simpkins, et al.. (1994). Dual metalloprotease inhibitors. III. utilization of bicyclic and monocyclic diazepinone based mercaptoacetyls. Bioorganic & Medicinal Chemistry Letters. 4(16). 2055–2060. 12 indexed citations
17.
Kim, Kyoung Soon, Ligang Qian, J. Eileen Bird, et al.. (1993). Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships. Journal of Medicinal Chemistry. 36(16). 2335–2342. 51 indexed citations
18.
Antonaccio, Michael J., John P. High, Bernard Rubin, & Thomas Schaeffer. (1979). Contribution of the Kidneys but not Adrenal Glands to the Acute Antihypertensive Effects of Captopril in Spontaneously Hypertensive Rats. Clinical Science. 57(s5). 127s–130s. 15 indexed citations
19.
Laffan, Robert J., et al.. (1978). Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.. Journal of Pharmacology and Experimental Therapeutics. 204(2). 281–288. 148 indexed citations
20.
Schaeffer, Thomas, et al.. (1973). Effects of the Nonapeptide SQ 20881 on Blood Pressure of Rats with Experimental Renovascular Hypertension. Experimental Biology and Medicine. 143(2). 483–487. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Tani Breakdown of academic impact, for papers by Carol A. Sargent Breakdown of academic impact, for papers by Serge Simonet Breakdown of academic impact, for papers by Maria Rosaria Rusciano Breakdown of academic impact, for papers by Tetsuhiro Kubota Breakdown of academic impact, for papers by Seiji Umemoto Breakdown of academic impact, for papers by Jan‐Arne Björkman Breakdown of academic impact, for papers by Fushun Yu Breakdown of academic impact, for papers by Benjamin Lauzier Breakdown of academic impact, for papers by Emilie Dubois‐Deruy
Rankless by CCL
2026